2. Hypertension is a common condition, affecting
about 20% of adults.
Secondary hypertension accounts for only 5%-
20%
of all cases of hypertension.
Causes of Secondary hypertension :
Kidney disease.
Tumours or other diseases of the adrenal gland.
Coarctation of the aorta .
Pregnancy.
Use of birth control pills.
Alcohol addiction.
Thyroid dysfunction.
3. Renovascular hypertension is the most common type
of secondary hypertension and is estimated to have a
prevalence between 0.5% and 5% of the general
hypertensive population.
The term renovascular hypertension (RVH) refers to the
causal relationship between a (RAS) and its clinical
consequences, namely, hypertension or renal failure.
Renal artery stenosis: narrowing or complete occlusion
of one or both renal arteries, defined by imaging at:
greater than 60% stenosis by Doppler or grater than
50% by angiography.
4. Causes of renal artery stenosis
Common etiologies
Atherosclerotic disease (90%)
Fibromuscular dysplasia (10%).
Less common etiologies
Vasculitis
Embolic disease.
Dissection.
Post-traumatic occlusion.
Extrinsic compression of a
renal artery or of a kidney.
5. Classification of renal artery
stenosis:
Unilateral.
Unilateral in a single
functional kidney.
Bilateral.
Proximal.
Distal.
Moderate stenosis ( 50%-75%
of RA diameter)
Sever stenosis( 75%)
Total occlusion.
SeverityAnatomical :
6. Pathophysiolo
gy
RAS ( 50%) under perfusion of the kidney
activation (renin - angiotensin system).
angiotensinogen angiotensin I.
angiotensin I angiotensin II.
Angiotensin II, a potent vasopressor responsible for the
vasoconstrictive element of renovascular hypertension.
Angiotensin II increases adrenal gland production of
aldosterone with subsequent retention of sodium and
water
7. Clinical Findings associated with renovascular
hypertension
Refractory hypertension.
Severe hypertension (diastolic blood pressure >120
mm Hg)
Hypertension associated with progressive renal
impairment.
Onset of hypertension before age 30 year.
Abrupt onset of hypertension.
Generalized atherosclerosis.
Abdominal bruit.
14. IVU
• The affected kidney small and smooth.
• The reduced perfusion on the affected side
produces a late nephrogram giving rise to a
hyperdense nephrogram.
• Notching of the ueretr due to compensatory
hypertrophy of the ureteric artery.
15. Ultrasound
• First step in the investigation.
• It is a simple non –invasive.
• Obvious size disparity between the two kidneys (2cm)
one kidney is abnormally small - slo unilateral RAS.
• Exclude an obvious structural abnormality coexistent
condition that may relate to the hypertension ( renal
scarring and rarely renal or adrenal tumours.
16.
17. Normal renal Doppler waveform
• Rapid systolic rise.
• High-velocity diastolic flow.
• Small spike at the end of the systolic rise
18. Normal renal Doppler waveform :
The PSV in the main renal artery less than 120 cm/sec.
Acceleration time is the time from the start of systole to peak systole.
A normal acceleration time for the main renal artery is less than 70 msec
19. RI = PSV - EDV ∕ PSV .
The values of RI in the main RA are higher in the hilar
region ( 50 : 80) than in the more distal small arteries.
20. Doppler criteria of RAS:
Direct criteria (proximal criteria ):
Main renal artery.
Site of the stenosis.
Indirect criteria (distal criteria ):
Intrarenal arteries
21. Direct US signs ( Proximal criteria):
1. Doppler US artifacts caused
by poststenotic turbulence
(aliasing).
2. Renal artery PSV > 180
cm/sec.
3. Renal artery PSV–to–
abdominal aorta PSV ratio >
3.5.
4. Lack of Doppler US signal in
cases of occlusion. Mosaic flow is seen within the stenotic
area spectral Doppler waveform of the
stenotic area in the right RA. Increased
peak systolic velocities are seen (PSV 286
cm/s);
22. Indirect US signs ( Distal criteria):
Loss of early systolic peak.
AT > 70 ms.
A difference between the kidneys RI
more than 5%.
Pulsus parvus et tardus
(blunted and delayed
systolic upstroke).
23. Direct and indirect US findings in a patient with secondary hypertension due to RAS.
(a) elevated PSV (>200 cm/sec.
(b) Sagittal US image shows a pulsus parvus et tardus waveform distal to the site of stenosis, where there is blunting of the
systolic peak with a delayed upstroke. This waveform is quantified on the basis of an acceleration time longer than 70 msc.
24. Magnetic Resonance Angiography
MRA is a non-invasive test for assessing RAS and has been widely
applied for clinical practice.
Contrast-enhanced MRA forms the backbone of MRI of renal arteries, but
noncontract MRA with spechial techniques has also been used for
evaluating the renal arteries.
Functional information can be added by measuring renal flow with cine
phase-contrast imaging. Diffusion and perfusion imaging can also be used
to measure renal ischemia. Another MR technique currently being
investigated, MRI BOLD , is able to assess renal oxygenation, which may
allow for functional assessment in patients with RAS .
25. Severe bilateral RAS (a) Coronal MIP image from MRA shows severe bilateral renal stenosis (arrows), which appear as
short occlusions. (b) Coronal source MR image shows left renal atrophy, suggesting that the left-sided stenosis is more
severe. A large renal cyst is also seen.
26. Exposure to gadolinium contrast agents in patients
with renal failure and those maintained on dialysis
has recently been linked with the development of
nephrogenic systemic fibrosis a debilitating and
sometimes fatal disease affecting the skin, muscle,
and internal organs.
27. The main limitations of MR angiography
are
Evaluation of branch vessels.
The presence of a metallic stent.
Detection of accessory arteries.
28. CTA
Contrast-enhanced CTA provides accurate anatomic images
of the renal arteries that enable the reconstruction of high-
resolution images in any plane.
Advantages compared with arteriography include less
invasiveness, faster acquisitions, and multiplanar imaging.
The disadvantages of this technique are its ionizing radiation
and its use of nephrotoxic contrast material.
Normal results from CTA virtually rule out RAS.
29. Atherosclerotic RAS in an 82-year-old man with hypertension. CR image (a) and coronal MIP (b) images from a
CT angiogram show a focal severe short segment of narrowing (arrow) of the proximal renal artery. Additional
atherosclerotic changes and a fusiform aneurysm are present in the infrarenal abdominal aorta (* in b).
In addition to directly visualized luminal narrowing, it also
show the secondary signs include poststenotic dilatation,
renal atrophy, and decreased cortical enhancement.
30. Coronal MIP CT A shows the presence of multiple alternating areas of narrowing and dilatation (arrow) of the right
renal artery. a “string of pearls” appearance (arrow) of the right main renal artery. This appearance is consistent with
FMD.
31. Renal Arteriography
Intra-arterial digital subtraction angiography
(IADSA) is considered the reference standard for
demonstrating RAS and is an integral part of
angioplasty and stenting procedures.
Angiography has high spatial resolution for
evaluating the main renal arteries as well as the
branch renal arteries.
32.
33.
34.
35.
36.
37.
38. ACE Inhibitor
Scintigraphy
Captopril renography is a functional assessment of renal perfusion.
In patients with unilateral RAS, a unilateral change in renal function
induced by ACE inhibition can be revealed with scintigraphy.
In these patients, ACE inhibitor scintigraphy induces significant
changes in the time-activity curves of the affected kidney in
comparison with baseline scintigraphy..
39. When using Tc 99m MAG3,a renogram curve showing:
• Diminished uptake.
• Flattened peak .
In sever cases the excretion may be also shows that the
curve continues rising through the period of observation
40. Renovascular disease in a 60-year-old
patient. (a) Baseline scintigram obtained
with Tc-99m MAG3 shows mild and
nonspecific abnormalities, with
decreased amplitude and delayed
peaking of the left renal curve
(arrowhead) relative to the right renal
curve (solid arrow).
(b) Scintigram obtained after
administration of captopril shows
diminished uptake in the left kidney, with
an abnormal curve (solid arrow)
suggesting left-sided renovascular
disease. The
44. Interventional radiology in the treatment of RAS
Percutaneous transluminal renal angioplasty alone
or in commination with stent implantation.
Selecting patients for renal revascularization:
• Refractory hypertension.
• Progressive azotemia.
• Recurrent pulmonary oedema.
• Bilateral renal artery stenosis
• Stenosis of renal artery supplying single functioning
kidney.
45.
46.
47.
48. US can be utilized regardless of level of renal
function.
CTA and MRA are both effective modalities for
diagnosis of RAS, though both have been associated
with potential morbidity in the setting of impaired renal
function nephrogenic systemic fibrosis (NSF) in the
case of MRI and contrast material–induced
nephropathy (CIN) in the case of CT .
Unenhanced CT does not provide useful diagnostic
information regarding RAS.
Non-contrast MRI protocols are an alternative in
patients with impaired renal function.
49. Renal scintigraphy also can be utilized for
functional assessement of RAS but has
decreased accuracy in patients with bilateral
RAS or impaired renal function.
Renin is released from the kidney in response to changes in renal cortical afferent arteriolar perfusion pressure. Renin acts locally and in the systemic circulation on renin substrate (angiotensinogen), a non vasoactive α2 globulin is produced in the liver to form angiotensin I. Angiotensin I undergoes enzymatic cleavage by ACE in the pulmonary circulation to produce angiotensin II, a potent vasopressor responsible for the vasoconstrictive element of renovascular hypertension.
that is difficult to control with medical treatment (no improvement with using 3 or more anti HTN drugs ).
20% of cardiac output is directed to the kidneys.
The main renal artery normally arises from the abdominal aorta, below the level of the superior mesenteric artery at the L2 vertebral body level.
Accessory renal arteries are found in about 30% of individuals and are present bilaterally in 10% of individuals.
Anomalous renal vasculature is much more common in patients who have renal fusion and positional anomalies.
all may be utilized in the diagnosis of RAS.
Normal renal parenchyma measures greater than 1 cm in thickness. The parenchyma surface should be smooth with an echogenicity equal to or slightly less than the normal liver parenchyma
SHAPE
RAS results in an increased PSV within the stenotic segment of the vessel and an increased acceleration time in the vessel distal to the stenotic segment.
The resistive index is calculated by dividing the difference between the PSV and end-diastolic velocity by the PSV .
1st and important sign is the increase in PSV. Velocity higher than 180 cm/sec suggest presence of stesnosis greater than 60%.
EDV greater than 150 cm/sec suggests degree of stenosis greater than 80%.
visualization of color artifacts such as aliasing at the site of stenosis and the presence of significant stenosis.
No detectable Doppler signal, a finding that indicates occlusion.
Wave form alterations distal to the stenosis in arterial segments ( hilar or interlobar).
(: a great difference in RI values obtained on the 2 kidneys ( > 0.05 – 0.07) is another criteron of diagnosis of RAS.
Duplex Doppler Ultrasonography:
Ultrasonography is less useful than magnetic resonance angiography for diagnosing fibromuscular dysplasia and detecting accessory renal arteries. Because of the difficulty and time involved with duplex Doppler ultrasonography, it should be used in medical centers where it has proven to be reliable and where dedicated technologists and physicians are skilled in this test.
with an IV of gadolinium-based contrast agent
steady-state free precession (SSFP) and arterial spin labelling
The reliability of MRA is not affected by the presence of bilateral renovascular disease.
it is now possible to evaluate not only the main renal arteries, but also the accessory renal arteries and distal stenosis.
blood oxygen level – dependent
The ACR guidelines for safe MRI practices state that for all patients with moderate to end-stage kidney disease (i.e., estimated glomerular filtration rate [GFR] of less than 60 mL per min per 1.73 m2) and those with acute renal injury, it is recommended that gadolinium contrast agents not be administered unless a risk-benefit assessment for that particular patient indicates that the benefit clearly outweighs the potential risks.
evaluation of small renal arteries.
RAS caused by atherosclerosis occurs at the origin of the renal artery or within the proximal 2 cm of the renal artery.
A pressure gradient >20 mm Hg, or >10% of mean arterial pressure, is considered to be an indicator of hemodynamic significance.
FMD in a 52-year-old woman with secondary hypertension.
Coronal MIP CT angiogram shows a “string of pearls” appearance (arrow) of the right main renal artery. This appearance is consistent with FMD.
(b) Digital subtraction angiogram confirms the presence of multiple alternating areas of narrowing and dilatation (arrow) of the right renal artery.
Accessory artery in a 35-year-old patient with severe hypertension.
Coronal MRA shows irregularities of the distal third of both main renal arteries, an appearance suggestive of fibromuscular dysplasia.
(c, d) Selective arteriograms of the right (c) and left (d) main renal arteries show mild fibromuscular dysplasia. Note the small parenchymal defect at the upper pole of the right kidney from the accessory artery.
(b) Conventional aortogram shows fibromuscular dysplasia involving both renal arteries. A possible accessory artery is seen on the right side (arrow).
Severe bilateral RAS (a) Coronal MIP image from MRA shows severe bilateral renal stenosis (arrows), which appear as short occlusions. (b) Coronal source MRI shows left renal atrophy, suggesting that the left-sided stenosis is more severe. A large renal cyst is also seen. (c, d) Selective arteriograms show a 70% stenosis of the right renal artery (c) and a 90% stenosis of the left renal artery
Overestimation of stenosis in a patient with hypertension. (a) Coronal MRA shows severe stenosis of the left main renal artery. No accessory artery is seen. (b) Conventional aortogram shows the stenosis of the left main renal artery, which was slightly overestimated on the MRA (a). In addition, a small accessory artery is demonstrated at the upper pole of the kidney (arrowhead).
and function rather than a method of directly visualizing the vasculature.
Such changes are not observed in patients with non significant RAS or normal renal arteries
The most specific diagnostic criterion for RVH at scintigraphy is Unilateral parenchymal retention after ACE inhibition is the most important criterion for Tc- 99m MAG3 scintigraphy.
Stenotic accessory artery in a 55-year-old patient with hypertension.
(a) Baseline Tc-99m DTPA scintigrams (sequential posterior views obtained at 2-minute intervals from top left to bottom right) show slight retention of the radiopharmaceutical in the left renal pelvis. (b) Captopril scintigrams show markedly decreased uptake in the upper half of the right kidney, a finding consistent with renovascular disease of a polar artery.
The sensitivity and specificity of this examination are decreased in patients without clinical features of renovascular hypertension and are also decreased in patients with bilateral RAS, impaired renal function, and urinary obstruction.
Indeterminate scintigraphic results in a 70-year-old patient with renal insufficiency. Baseline (a) and captopril (b) Tc-99m DTPA scintigrams (sequential images obtained at 2-minute intervals from top left to bottom right) show poor demonstration of both kidneys. No conclusion could be drawn about the possibility of renovascular disease.
However, among patients with a significant RAS, only two-thirds show improvement of hypertension after revascularization and 27%–80% show improvement or stabilization of renal function.
When left untreated, atheromatous RAS tends to worsen, leading to renal artery thrombosis. In addition, medical treatment of RVH has been proved to be less effective than percutaneous or surgical revascularization.
Therefore, patients suspected of having RVH should undergo adequate screening.
A balloon angioplasty catheter is seen in situ across the left renal artery stenosis , after angioplasty an excellent anatomic ( and functional ) result was achieved.
Fibrous dysplasia with stent.
The main challenge is not to detect all cases of RAS 50% or greater in diameter but to identify stenoses that will benefit from revascularization. Another major issue is avoidance of unnecessary diagnostic angiography, especially in patients with renal failure.
From this perspective, screening should begin with a functional investigation such as Doppler US or scintigraphy. In a center with good expertise with Doppler US, the cost-effectiveness of this technique is probably superior to that of scintigraphy.
MRA , with its higher cost and lesser availability, should be reserved for patients with indeterminate functional imaging results, patients with normal functional imaging results but high clinical suspicion of RVH, and patients with abnormal functional imaging results who have a contraindication to conventional angiography, such as renal failure or a history of allergy to iodinated contrast material
MRA
Contrast-enhanced MRA may be precluded because of the risk of NSF with eGFR <30 mL/min/1.73 m2. In these patients, unenhanced MRA techniques are available as an alternative to contrast-enhanced MRA to avoid the risk of NSF.